3 not yet recruiting. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 3 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Cachexia-Anorexia Syndrome: new trials by email Literature Review of Cachexia-Anorexia Syndrome trials Research Report on Cachexia-Anorexia Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Clinical Study Evaluating the Efficacy and Safety of SXRN Injection in Patients With Cancer Cachexia SXRN Injection, Placebo - Cachexia-Anorexia Syndrome, Cachexia; Cancer | Phase 2 | Not yet recruiting | Jiangsu Guiqiong Pharmaceutical Co., Ltd. | 96 | 2026-12-01 | 2026-10-26 |
| Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLC Rilogrotug, Placebo - Cachexia; Cancer, Cachexia | Phase 2 / Phase 3 | Not yet recruiting | AVEO Pharmaceuticals, Inc. | 950 | 2026-11-01 | 2026-10-28 |
| Nano-crystalline Megestrol Acetate for Anorexia-Cachexia Syndrome in Advanced Lung Cancer Nano-crystalline Megestrol Acetate Oral Suspension, Nano-crystalline Megestrol Acetate Oral Suspension placebo - Lung Cancer, Cachexia-Anorexia Syndrome | Phase 2 | Not yet recruiting | Guangzhou Institute of Respiratory Disease | 116 | 2025-10-10 | 2025-07-29 |
Cachexia (2) · Neoplasms (2) · Anorexia (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Lung Neoplasms (1) · Weight Loss (1)
Body Weight (2) · Body Weight Changes (2) · Lung Diseases (2) · Neoplasms by Site (2) · Pathological Conditions, Signs and Symptoms (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Signs and Symptoms (2) · Thinness (2) · Thoracic Neoplasms (2) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1)
AVEO Pharmaceuticals, Inc. (1) · Guangzhou Institute of Respiratory Disease (1) · Jiangsu Guiqiong Pharmaceutical Co., Ltd. (1)
China (1)